Karin Hansson

6PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 19, 2026
Combined ATR and mitotic inhibition is effective against MYCN-amplified neuroblastoma.

|Dec 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Katarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos

|Oct 17, 2024
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.

Jenny Karlsson, Hiroaki Yasui, Adriana Mañas

|Apr 28, 2023
USP7 controls NGN3 stability and pancreatic endocrine lineage development.

Teodora Manea, Jessica Kristine Nelson, Cristina Maria Garrone

|Oct 28, 2022
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.

Adriana Mañas, Kristina Aaltonen, Natalie Andersson

|Sep 24, 2020
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma.

Karin Hansson, Katarzyna Radke, Kristina Aaltonen

Pageof 1

Frequent Collaborators

5 joint publications

Daniel Bexell

4 joint publications

Katarzyna Radke

4 joint publications

Kristina Aaltonen

3 joint publications

Adriana Mañas